33 related articles for article (PubMed ID: 2142921)
1. Goserelin-Induced Chemical Burn: A Case Report and Review of the Literature.
Mahadevan A; Warnecke B; Chiao E; Nafissi N; Parajuli K; Rijal N; Parajuli R
Cureus; 2023 Sep; 15(9):e45692. PubMed ID: 37745751
[TBL] [Abstract][Full Text] [Related]
2. Clinical applications of gonadotropin-releasing hormone analogues: a broad impact on reproductive medicine.
Saleh FL; Taylor HS
F S Rep; 2023 Jun; 4(2 Suppl):83-87. PubMed ID: 37223759
[TBL] [Abstract][Full Text] [Related]
3. Medical Therapies for Uterine Fibroids - A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials.
Gurusamy KS; Vaughan J; Fraser IS; Best LM; Richards T
PLoS One; 2016; 11(2):e0149631. PubMed ID: 26919185
[TBL] [Abstract][Full Text] [Related]
4. Add-back therapy with GnRH analogues for uterine fibroids.
Moroni RM; Martins WP; Ferriani RA; Vieira CS; Nastri CO; Candido Dos Reis FJ; Brito LG
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010854. PubMed ID: 25793972
[TBL] [Abstract][Full Text] [Related]
5. Fibroids (uterine myomatosis, leiomyomas).
Lethaby A; Vollenhoven B
BMJ Clin Evid; 2011 Jan; 2011():. PubMed ID: 21477393
[TBL] [Abstract][Full Text] [Related]
6. Fibroids (uterine myomatosis, leiomyomas).
Lethaby AE; Vollenhoven BJ
BMJ Clin Evid; 2007 May; 2007():. PubMed ID: 19454074
[TBL] [Abstract][Full Text] [Related]
7. Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders.
Perry CM; Brogden RN
Drugs; 1996 Feb; 51(2):319-46. PubMed ID: 8808170
[TBL] [Abstract][Full Text] [Related]
8. Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions.
Chrisp P; Goa KL
Drugs; 1991 Feb; 41(2):254-88. PubMed ID: 1709853
[TBL] [Abstract][Full Text] [Related]
9. Goserelin acetate implant: a depot luteinizing hormone-releasing hormone analog for advanced prostate cancer.
Goldspiel BR; Kohler DR
DICP; 1991; 25(7-8):796-804. PubMed ID: 1835221
[TBL] [Abstract][Full Text] [Related]
10. Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot.
Costantini S; Anserini P; Valenzano M; Remorgida V; Venturini PL; De Cecco L
Eur J Obstet Gynecol Reprod Biol; 1990 Oct; 37(1):63-9. PubMed ID: 2142921
[TBL] [Abstract][Full Text] [Related]
11. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot.
West CP; Lumsden MA; Lawson S; Williamson J; Baird DT
Fertil Steril; 1987 Jul; 48(1):45-51. PubMed ID: 2954863
[TBL] [Abstract][Full Text] [Related]
12. [Preoperative reduction of uterine leiomyoma by the GnRH-analog goserelin (zoladex)].
Hackenberg R; Gesenhues T; Deichert U; Duda V; Sturm G; Schulz KD
Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):136-9. PubMed ID: 2138580
[TBL] [Abstract][Full Text] [Related]
13. Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase.
Healy DL; Lawson SR; Abbott M; Baird DT; Fraser HM
J Clin Endocrinol Metab; 1986 Sep; 63(3):619-25. PubMed ID: 3090092
[TBL] [Abstract][Full Text] [Related]
14. Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: a pilot study.
Maheux R; Guilloteau C; Lemay A; Bastide A; Fazekas AT
Am J Obstet Gynecol; 1985 Aug; 152(8):1034-8. PubMed ID: 3927734
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
